Champions Oncology Inc

NASDAQ:CSBR   2:03:01 PM EDT
10.25
-0.21 (-2.01%)
Earnings Announcements

Champions Biotechnology Says Q4 Revenue Increased 21% To $10.6 Mln

Published: 07/22/2021 13:14 GMT
Champions Oncology Inc (CSBR) - Champions Biotechnology Inc - for Q4 Fiscal 2021, Revenue Increased 21% to $10.6 Million Versus $8.8 Million for Q4 of Fiscal 2020.
Champions Biotechnology Inc - Qtrly Basic Loss per Share $0.04.
Champions Biotechnology Inc - Qtrly Basic Adjusted.
Loss per Share $0.03.
Further Company Coverage: Csbro ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $10.95 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $11.54 Million
Next Quarter EPS Guidance is expected to be $0.03

More details on our Analysts Page.